A citation-based method for searching scientific literature

Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León, Coman Tanasescu, Eugeny Nasonov, Joung-Liang Lan, Lilia Pineda, Z John Zhong, William Freimuth, Michelle A Petri. Lancet 2011
Times Cited: 917







List of co-cited articles
722 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
720
66

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
650
26

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni,[...]. Ann Rheum Dis 2019
308
26

Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Eric F Morand, Richard Furie, Yoshiya Tanaka, Ian N Bruce, Anca D Askanase, Christophe Richez, Sang-Cheol Bae, Philip Z Brohawn, Lilia Pineda, Anna Berglind,[...]. N Engl J Med 2020
156
26

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E Hammer, Christi Kleoudis, James Groark, Damon Bass, Norma Lynn Fox,[...]. Arthritis Rheumatol 2017
111
25

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
628
25

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
336
20

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.
Fengchun Zhang, Sang-Cheol Bae, Damon Bass, Myron Chu, Sally Egginton, David Gordon, David A Roth, Jie Zheng, Yoshiya Tanaka. Ann Rheum Dis 2018
55
34



Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
Ronald F van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth. Ann Rheum Dis 2012
214
16

Combined oral contraceptives in women with systemic lupus erythematosus.
Michelle Petri, Mimi Y Kim, Kenneth C Kalunian, Jennifer Grossman, Bevra H Hahn, Lisa R Sammaritano, Michael Lockshin, Joan T Merrill, H Michael Belmont, Anca D Askanase,[...]. N Engl J Med 2005
573
16


Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
246
16

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
151
15

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
M A Dooley, F Houssiau, C Aranow, D P D'Cruz, A Askanase, D A Roth, Z J Zhong, S Cooper, W W Freimuth, E M Ginzler. Lupus 2013
142
12

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.
Ronald F van Vollenhoven, Marta Mosca, George Bertsias, David Isenberg, Annegret Kuhn, Kirsten Lerstrøm, Martin Aringer, Hendrika Bootsma, Dimitrios Boumpas, Ian N Bruce,[...]. Ann Rheum Dis 2014
282
12

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy. Ann Rheum Dis 2016
191
11

Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz. J Rheumatol 2002
11

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Kate Franklyn, Chak Sing Lau, Sandra V Navarra, Worawit Louthrenoo, Aisha Lateef, Laniyati Hamijoyo, C Singgih Wahono, Shun Le Chen, Ou Jin, Susan Morton,[...]. Ann Rheum Dis 2016
163
11

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Michelle Petri, William Stohl, Winn Chatham, W Joseph McCune, Marc Chevrier, Jeff Ryel, Virginia Recta, John Zhong, William Freimuth. Arthritis Rheum 2008
244
11

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Y K Onno Teng, Ian N Bruce, Betty Diamond, Richard A Furie, Ronald F van Vollenhoven, David Gordon, James Groark, Robert B Henderson, Mary Oldham, Paul P Tak. BMJ Open 2019
31
32

Novel evidence-based systemic lupus erythematosus responder index.
Richard A Furie, Michelle A Petri, Daniel J Wallace, Ellen M Ginzler, Joan T Merrill, William Stohl, W Winn Chatham, Vibeke Strand, Arthur Weinstein, Marc R Chevrier,[...]. Arthritis Rheum 2009
250
10


Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study.
Ronald F van Vollenhoven, Bevra H Hahn, George C Tsokos, Carrie L Wagner, Peter Lipsky, Zahi Touma, Victoria P Werth, Robert M Gordon, Bei Zhou, Benjamin Hsu,[...]. Lancet 2018
115
10



The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.
D Gladman, E Ginzler, C Goldsmith, P Fortin, M Liang, M Urowitz, P Bacon, S Bombardieri, J Hanly, E Hay,[...]. Arthritis Rheum 1996
9


Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Megan E B Clowse, Daniel J Wallace, Richard A Furie, Michelle A Petri, Marilyn C Pike, Piotr Leszczyński, C Michael Neuwelt, Kathryn Hobbs, Mauro Keiserman, Liliana Duca,[...]. Arthritis Rheumatol 2017
81
11


Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples.
Venkat Reddy, Christian Klein, David A Isenberg, Martin J Glennie, Geraldine Cambridge, Mark S Cragg, Maria J Leandro. Rheumatology (Oxford) 2017
45
20

Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study.
Richard Furie, Kathy Nicholls, Tien-Tsai Cheng, Frederic Houssiau, Ruben Burgos-Vargas, Shun-Le Chen, Jan L Hillson, Stephanie Meadows-Shropshire, Michael Kinaszczuk, Joan T Merrill. Arthritis Rheumatol 2014
178
9

New therapies for systemic lupus erythematosus - past imperfect, future tense.
Grainne Murphy, David A Isenberg. Nat Rev Rheumatol 2019
45
20

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.
William Stohl, Falk Hiepe, Kevin M Latinis, Mathew Thomas, Morton A Scheinberg, Ann Clarke, Cynthia Aranow, Frank R Wellborne, Carlos Abud-Mendoza, Douglas R Hough,[...]. Arthritis Rheum 2012
198
8

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.
J Zhang, V Roschke, K P Baker, Z Wang, G S Alarcón, B J Fessler, H Bastian, R P Kimberly, T Zhou. J Immunol 2001
505
8

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.
Daniel J Wallace, William Stohl, Richard A Furie, Jeffrey R Lisse, James D McKay, Joan T Merrill, Michelle A Petri, Ellen M Ginzler, W Winn Chatham, W Joseph McCune,[...]. Arthritis Rheum 2009
324
8



Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study.
Daniel J Wallace, Kenneth Kalunian, Michelle A Petri, Vibeke Strand, Frederic A Houssiau, Marilyn Pike, Brian Kilgallen, Sabine Bongardt, Anna Barry, Lexy Kelley,[...]. Ann Rheum Dis 2014
157
8

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
8

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.
Ioannis Parodis, Christopher Sjöwall, Andreas Jönsen, Daniel Ramsköld, Agneta Zickert, Martina Frodlund, Azita Sohrabian, Laurent Arnaud, Johan Rönnelid, Vivianne Malmström,[...]. Autoimmun Rev 2017
40
20

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Tobias Alexander, Ramona Sarfert, Jens Klotsche, Anja A Kühl, Andrea Rubbert-Roth, Hannes-Martin Lorenz, Jürgen Rech, Bimba F Hoyer, Qingyu Cheng, Aderajew Waka,[...]. Ann Rheum Dis 2015
169
8

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
George K Bertsias, Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria,[...]. Ann Rheum Dis 2012
539
8

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
667
8

Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.
Richard A Furie, Daniel J Wallace, Cynthia Aranow, James Fettiplace, Barbara Wilson, Prafull Mistry, David A Roth, David Gordon. Arthritis Rheumatol 2018
26
30

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
William Stohl, Samy Metyas, Soon-Min Tan, Gurtej S Cheema, Bonifacia Oamar, Dong Xu, Viktor Roschke, Youmei Wu, Kevin P Baker, David M Hilbert. Arthritis Rheum 2003
320
8

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Richard Furie, Brad H Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B Santiago,[...]. N Engl J Med 2020
40
20

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Ian N Bruce, Aidan G O'Keeffe, Vern Farewell, John G Hanly, Susan Manzi, Li Su, Dafna D Gladman, Sang-Cheol Bae, Jorge Sanchez-Guerrero, Juanita Romero-Diaz,[...]. Ann Rheum Dis 2015
193
7

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
F Mackay, S A Woodcock, P Lawton, C Ambrose, M Baetscher, P Schneider, J Tschopp, J L Browning. J Exp Med 1999
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.